Chemotype‐Resolved Cytoprotection of CAM Hydrothermal Extracts Validated in 2D/3D Fibroblast Models and Supported by In Silico Target Profiling
Chemistry & Biodiversity · 2026-07 · 23 (7)
DOI: 10.1002/cbdv.71484 ↗At a glance
Journal article in Chemistry & Biodiversity, published online on 2026-07-08. Written by Eun Hye Park and 1 co-authors. Institution: Department of Biotechnology, College of Life and Health Sciences, Hoseo University, Asan, Chungnam, Republic of Korea. Major MEDLINE topics: Plant Extracts, Cytoprotection, Fibroblasts, Antioxidants. 31 references.
Abstract (original language)
Crassulacean Acid Metabolism (CAM) plants possess unique stress‐adaptive physiologies, yet their chemotype‐bioactivity relationships remain poorly understood. We established an integrated workflow combining GC–MS metabolomics, 2D/3D functional validation, and in silico profiling to evaluate hydrothermal extracts from four CAM species (BDAE [ Bulbophyllum drymoglossum ], CRSAE [ Crassula rupestris ], ECAE [ Echeveria ], and STAE [ Hylotelephium telephium ]). PCA and marker analysis resolved three distinct chemotypes: acid‐rich, sugar‐rich, and lipid/sterol‐enriched. Using standardized noncytotoxic concentrations, we demonstrated that acid‐rich extracts (BDAE/CRSAE) most consistently attenuated H 2 O 2 ‐induced oxidative stress in NIH/3T3 fibroblasts. These cytoprotective effects included significant ROS reduction and preservation of mitochondrial membrane potential. Importantly, these antioxidant properties were robustly retained in a 3D bioprinted tissue‐mimetic model with high biocompatibility, as confirmed by live/dead imaging. Furthermore, in silico docking justifies prioritizing phaselic acid as a bioactive marker, showing reproducible interactions with Keap1, COX‐2, and MMP‐1. While acknowledging the specific analytical scope of GC–MS and the predictive nature of computational modeling, this study successfully connects chemical composition, biological activity, and mechanistic hypotheses within a robust chemotype‐resolved framework. Our findings offer a strategic scientific rationale for the selective application of CAM‐derived metabolites in antioxidant strategies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biotechnology, College of Life and Health Sciences, Hoseo University, Asan, Chungnam, Republic of Korea.
- CANDIGEN Co., Ltd. Beonyeong-ro, Cheonan-si, Chungcheongnam-do, Republic of Korea.
ORCID profiles: Sung-Jo Kim
Cite
APA
Park, E. H., & Kim, S. J. (2026). Chemotype‐Resolved Cytoprotection of CAM Hydrothermal Extracts Validated in 2D/3D Fibroblast Models and Supported by In Silico Target Profiling. Chemistry & Biodiversity, 23(7). https://doi.org/10.1002/cbdv.71484
Vancouver
Park EH, Kim SJ. Chemotype‐Resolved Cytoprotection of CAM Hydrothermal Extracts Validated in 2D/3D Fibroblast Models and Supported by In Silico Target Profiling. Chemistry & Biodiversity. 2026;23(7). doi:10.1002/cbdv.71484
BibTeX
@article{Park2026,
author = {Park, Eun Hye and Kim, Sung-Jo},
title = {Chemotype‐Resolved Cytoprotection of CAM Hydrothermal Extracts Validated in 2D/3D Fibroblast Models and Supported by In Silico Target Profiling},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {7},
doi = {10.1002/cbdv.71484}
}
EUVIMED